|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/137 | (2006.01) |
| A61K 45/06 | (2006.01) | ||
| A61P 35/04 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3834824 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21151737.0 |
| Date of filing the European patent application | 2015-03-28 | |
| (97) | Date of publication of the European application | 2021-06-16 |
| (45) | Date of publication and mention of the grant of the patent | 2025-10-22 |
| (46) | Date of publication of the claims translation | 2025-12-10 |
| (30) | Number | Date | Country code |
| 201461971627 P | 2014-03-28 | US | |
| 201414512061 | 2014-10-10 | US | |
| 201562129379 P | 2015-03-06 | US |
| (72) |
WARDELL, Suzanne, E. , US
NELSON, Erik, R. , US
MCDONNELL, Donald, P. , US
|
| (73) |
Duke University ,
2812 Erwin Road, Suite 306, Durham, NC 27705,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Estrogenų receptorių atžvilgiu teigiamo krūties vėžio gydymas, panaudojant estrogenų receptorių moduliatorių |
| TREATMENT OF AN ESTROGEN RECEPTOR POSITIVE BREAST CANCER USING A SELECTIVE ESTROGEN RECEPTOR MODULATOR |
| Payment date | Validity (years) | Amount | |
| 2026-03-03 | 12 | 289.00 EUR |
| 2027-03-28 |